IMAXXAM, an independent partner for the management of real estate investments, has acquired a life science campus in Fangdieckstraße in Hamburg. The property is intended for the “German Small Asset Invest (GSAI)” fund. The transaction was carried out as an asset deal. The seller of the property is CLS Holdings.
The building complexes, which were completed in 2000, have around 13,116 square metres of rental space. These are spread over five above-ground floors and one basement. The utilisation concept includes office, service, laboratory, training and storage space. The property also includes 109 underground parking spaces and 55 outdoor parking spaces.
The property is almost fully let. The anchor tenant is MVZ HPH Institut für Pathologie und Hämatopathologie GmbH, which has been associated with the site for many years. The space is tailored to the requirements of the local users.
“With this acquisition, we are investing in an established life science property with a high location quality and a loyal anchor tenant. The combination of specialized space, stable leasing and flexible usage options makes the property a convincing addition to our portfolio,” says Simon van Zoggel, Head of Transaction at IMAXXAM.
The campus has good public transport connections. The Hamburg-Eidelstedt S-Bahn station and several bus lines are nearby. The property is also directly connected to the regional and national road network via the A7 motorway and the B4 federal road. Hamburg’s main train station and the airport are also easily accessible.
With this acquisition, IMAXXAM is strengthening its commitment to the segment of future-oriented corporate and research real estate. Life science locations benefit from the growing demand for specialized laboratory, diagnostics and office space as well as from the long-term location commitment of their users.
Norton Rose Fulbright was responsible for the legal and tax due diligence, and WS Real Estate was responsible for the technical due diligence.
